Intravenous fat emulsions and lung function: A review

B. Skeie, J. Askanazi, Michael Rothkopf, S. H. Rosenbaum, V. Kvetan, B. Thomashow

Research output: Contribution to journalReview article

89 Citations (Scopus)

Abstract

Numerous studies have reported varying degrees of apparent pulmonary dysfunction when iv fat emulsions (IVFE) are given. These changes have generally not been of sufficient magnitude to carry clinical significance. The lung dysfunction observed has been attributed to an associated hyperlipemia. Recent studies, however, suggest that the associated impairment in lung function is due to alterations in pulmonary vascular tone (which results in ventilation/perfusion inequalities) caused by an IVFE-related increase in prostaglandin (PG) production. The polyunsaturated fatty acids in the IVFE serve as precursors to the PGs. Due to the varied effects of PGs on inflammation and pulmonary vasomotor tone, infusion of IVFE could have profound physiologic and pharmacologic actions aside from the provision of lipid calories. In some circumstances, IVFE may, in fact, be beneficial to the lung via alterations in PG synthesis and surfactant production.

Original languageEnglish (US)
Pages (from-to)183-194
Number of pages12
JournalCritical Care Medicine
Volume16
Issue number2
DOIs
StatePublished - Jan 1 1988
Externally publishedYes

Fingerprint

Intravenous Fat Emulsions
Emulsions
Fats
Lung
Prostaglandins
Pharmacologic Actions
Hyperlipidemias
Unsaturated Fatty Acids
Surface-Active Agents
Blood Vessels
Ventilation
Pneumonia
Perfusion
Lipids

All Science Journal Classification (ASJC) codes

  • Critical Care and Intensive Care Medicine

Cite this

Skeie, B., Askanazi, J., Rothkopf, M., Rosenbaum, S. H., Kvetan, V., & Thomashow, B. (1988). Intravenous fat emulsions and lung function: A review. Critical Care Medicine, 16(2), 183-194. https://doi.org/10.1097/00003246-198802000-00018
Skeie, B. ; Askanazi, J. ; Rothkopf, Michael ; Rosenbaum, S. H. ; Kvetan, V. ; Thomashow, B. / Intravenous fat emulsions and lung function : A review. In: Critical Care Medicine. 1988 ; Vol. 16, No. 2. pp. 183-194.
@article{9f78d044358f4e319f13f1d922efd36b,
title = "Intravenous fat emulsions and lung function: A review",
abstract = "Numerous studies have reported varying degrees of apparent pulmonary dysfunction when iv fat emulsions (IVFE) are given. These changes have generally not been of sufficient magnitude to carry clinical significance. The lung dysfunction observed has been attributed to an associated hyperlipemia. Recent studies, however, suggest that the associated impairment in lung function is due to alterations in pulmonary vascular tone (which results in ventilation/perfusion inequalities) caused by an IVFE-related increase in prostaglandin (PG) production. The polyunsaturated fatty acids in the IVFE serve as precursors to the PGs. Due to the varied effects of PGs on inflammation and pulmonary vasomotor tone, infusion of IVFE could have profound physiologic and pharmacologic actions aside from the provision of lipid calories. In some circumstances, IVFE may, in fact, be beneficial to the lung via alterations in PG synthesis and surfactant production.",
author = "B. Skeie and J. Askanazi and Michael Rothkopf and Rosenbaum, {S. H.} and V. Kvetan and B. Thomashow",
year = "1988",
month = "1",
day = "1",
doi = "10.1097/00003246-198802000-00018",
language = "English (US)",
volume = "16",
pages = "183--194",
journal = "Critical Care Medicine",
issn = "0090-3493",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

Skeie, B, Askanazi, J, Rothkopf, M, Rosenbaum, SH, Kvetan, V & Thomashow, B 1988, 'Intravenous fat emulsions and lung function: A review', Critical Care Medicine, vol. 16, no. 2, pp. 183-194. https://doi.org/10.1097/00003246-198802000-00018

Intravenous fat emulsions and lung function : A review. / Skeie, B.; Askanazi, J.; Rothkopf, Michael; Rosenbaum, S. H.; Kvetan, V.; Thomashow, B.

In: Critical Care Medicine, Vol. 16, No. 2, 01.01.1988, p. 183-194.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Intravenous fat emulsions and lung function

T2 - A review

AU - Skeie, B.

AU - Askanazi, J.

AU - Rothkopf, Michael

AU - Rosenbaum, S. H.

AU - Kvetan, V.

AU - Thomashow, B.

PY - 1988/1/1

Y1 - 1988/1/1

N2 - Numerous studies have reported varying degrees of apparent pulmonary dysfunction when iv fat emulsions (IVFE) are given. These changes have generally not been of sufficient magnitude to carry clinical significance. The lung dysfunction observed has been attributed to an associated hyperlipemia. Recent studies, however, suggest that the associated impairment in lung function is due to alterations in pulmonary vascular tone (which results in ventilation/perfusion inequalities) caused by an IVFE-related increase in prostaglandin (PG) production. The polyunsaturated fatty acids in the IVFE serve as precursors to the PGs. Due to the varied effects of PGs on inflammation and pulmonary vasomotor tone, infusion of IVFE could have profound physiologic and pharmacologic actions aside from the provision of lipid calories. In some circumstances, IVFE may, in fact, be beneficial to the lung via alterations in PG synthesis and surfactant production.

AB - Numerous studies have reported varying degrees of apparent pulmonary dysfunction when iv fat emulsions (IVFE) are given. These changes have generally not been of sufficient magnitude to carry clinical significance. The lung dysfunction observed has been attributed to an associated hyperlipemia. Recent studies, however, suggest that the associated impairment in lung function is due to alterations in pulmonary vascular tone (which results in ventilation/perfusion inequalities) caused by an IVFE-related increase in prostaglandin (PG) production. The polyunsaturated fatty acids in the IVFE serve as precursors to the PGs. Due to the varied effects of PGs on inflammation and pulmonary vasomotor tone, infusion of IVFE could have profound physiologic and pharmacologic actions aside from the provision of lipid calories. In some circumstances, IVFE may, in fact, be beneficial to the lung via alterations in PG synthesis and surfactant production.

UR - http://www.scopus.com/inward/record.url?scp=0023900926&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023900926&partnerID=8YFLogxK

U2 - 10.1097/00003246-198802000-00018

DO - 10.1097/00003246-198802000-00018

M3 - Review article

C2 - 3277776

AN - SCOPUS:0023900926

VL - 16

SP - 183

EP - 194

JO - Critical Care Medicine

JF - Critical Care Medicine

SN - 0090-3493

IS - 2

ER -